Massive pulmonary embolism with intra-hospital cardiac arrest and full recovery of right ventricular function after veno-arterial extracorporeal membrane oxygenation therapy: a case report.

Background Massive pulmonary embolism (PE) with shock constitutes a life-threatening disease, challenging physicians with the need for fast decision-making in an emergency situation. While thrombolytic treatment or thrombectomy are considered the treatment of choice in high-risk PE, these strategies might not be able to unload the right ventricle (RV) fast enough in some patients with severe cardiogenic shock. Case summary We present a case of a patient with massive bilateral central PE who presented in cardiogenic shock, rapidly deteriorating to cardiac arrest. After successful re-establishing spontaneous circulation, the patient remained highly unstable, necessitating a treatment strategy ensuring a quick stabilization of the circulation. Therefore, we decided to use veno-arterial extracorporeal membrane oxygenation (vaECMO) as a supportive strategy allowing for autolysis of the lung to dissolve the thrombi (bridge to recovery). We were able to wean the patient from vaECMO support within 4 days and documented a complete recovery of right ventricular in echocardiography before hospital discharge. Discussion The concept of vaECMO treatment alone might be a valuable alternative in selected patients with massive PE and cardiogenic shock, in whom thrombolytic therapy might not unload the RV fast enough.

[1]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .

[2]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.

[3]  S. Prasad,et al.  National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism , 2019, Vascular medicine.

[4]  B. Rasmussen,et al.  Extracorporeal membrane oxygenation in life-threatening massive pulmonary embolism , 2019, Perfusion.

[5]  Mazen S. Albaghdadi,et al.  Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a case series and review of the literature , 2018, Perfusion.

[6]  R. Favory,et al.  Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases , 2018, European heart journal.

[7]  P. Leprince,et al.  Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation , 2017, Critical Care.

[8]  E. Vicaut,et al.  Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. , 2017, Journal of the American College of Cardiology.

[9]  Ryan P. Barbaro,et al.  Extracorporeal Life Support Organization Registry International Report 2016 , 2017, ASAIO journal.

[10]  H. Vliegen,et al.  Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism , 2016, Journal of thrombosis and haemostasis : JTH.

[11]  F. Masud,et al.  Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients , 2014, Perfusion.

[12]  D. Spielvogel,et al.  Peripheral extracorporeal membrane oxygenation: comprehensive therapy for high-risk massive pulmonary embolism. , 2012, The Annals of thoracic surgery.

[13]  L. Goodman,et al.  Resolution of pulmonary embolism on CT pulmonary angiography. , 2010, AJR. American journal of roentgenology.

[14]  E. Oger,et al.  Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.

[15]  C. Kearon,et al.  Natural History of Venous Thromboembolism , 2003, Circulation.

[16]  J. Viel,et al.  Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. , 1998, Journal of the American College of Cardiology.